Yi KY - Search Results

1

Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma.

Hwang SY, Woo HY, Heo J, Kim HJ, Park YJ, Yi KY, Lee YR, Park SY, Chung WJ, Jang BK, Tak WY. Hwang SY, et al. Among authors: yi ky. Cancers (Basel). 2024 Feb 19;16(4):838. doi: 10.3390/cancers16040838. Cancers (Basel). 2024. PMID: 38398229 Free PMC article.

2

Patient-derived Organoid Model for Predicting the Chemoresponse in Patients With Colorectal Cancer.

Yi K, Park SH, Kim DU, Jeon DY, Lee HJ, Song GA, Jo HJ, Baek DH, Han JH, Lee BC. Yi K, et al. In Vivo. 2023 Jul-Aug;37(4):1751-1759. doi: 10.21873/invivo.13263. In Vivo. 2023. PMID: 37369516 Free PMC article.

3

An Unusual Cause of Recurrent Subepithelial Mass in the Stomach.

Yi K, Kim GH, Kim K. Yi K, et al. Gastroenterology. 2022 Apr;162(4):e1-e2. doi: 10.1053/j.gastro.2021.07.036. Epub 2021 Jul 27. Gastroenterology. 2022. PMID: 34329629 No abstract available.

4

Metastatic pancreatic solitary fibrous tumor: A case report.

Yi K, Lee J, Kim DU. Yi K, et al. World J Clin Cases. 2023 Dec 16;11(35):8416-8424. doi: 10.12998/wjcc.v11.i35.8416. World J Clin Cases. 2023. PMID: 38130626 Free PMC article.

5

Long-term outcomes of endoscopic resection for duodenal neuroendocrine tumors.

Yi K, Kim GH, Kim SJ, Choi CW, Lee MW, Lee BE, Song GA. Yi K, et al. Sci Rep. 2023 Oct 20;13(1):17908. doi: 10.1038/s41598-023-45243-8. Sci Rep. 2023. PMID: 37863959 Free PMC article.

6

KR-39038, a Novel GRK5 Inhibitor, Attenuates Cardiac Hypertrophy and Improves Cardiac Function in Heart Failure.

Lee JH, Seo HW, Ryu JY, Lim CJ, Yi KY, Oh KS, Lee BH. Lee JH, et al. Among authors: yi ky. Biomol Ther (Seoul). 2020 Sep 1;28(5):482-489. doi: 10.4062/biomolther.2020.129. Biomol Ther (Seoul). 2020. PMID: 32856617 Free PMC article.

7

Synthesis and SAR of 5-aryl-furan-2-carboxamide derivatives as potent urotensin-II receptor antagonists.

Lim CJ, Kim NH, Park HJ, Lee BH, Oh KS, Yi KY. Lim CJ, et al. Among authors: yi ky. Bioorg Med Chem Lett. 2019 Feb 15;29(4):577-580. doi: 10.1016/j.bmcl.2018.12.058. Epub 2018 Dec 29. Bioorg Med Chem Lett. 2019. PMID: 30611618

8

Identification of N-(5-(phenoxymethyl)-1,3,4-thiadiazol-2-yl)acetamide derivatives as novel protein tyrosine phosphatase epsilon inhibitors exhibiting anti-osteoclastic activity.

Ku B, Yun HY, Lee KW, Shin HC, Lee SR, Kim CH, Park H, Yi KY, Lee CH, Kim SJ. Ku B, et al. Among authors: yi ky. Bioorg Med Chem. 2018 Oct 1;26(18):5204-5211. doi: 10.1016/j.bmc.2018.09.022. Epub 2018 Sep 19. Bioorg Med Chem. 2018. PMID: 30249496

9

Cardioprotective effect of KR-33889, a novel PARP inhibitor, against oxidative stress-induced apoptosis in H9c2 cells and isolated rat hearts.

Park ES, Kang DH, Kang JC, Jang YC, Lee MJ, Chung HJ, Yi KY, Kim DE, Kim B, Shin HS. Park ES, et al. Among authors: yi ky. Arch Pharm Res. 2017 May;40(5):640-654. doi: 10.1007/s12272-017-0912-3. Epub 2017 Apr 4. Arch Pharm Res. 2017. PMID: 28378219

10

A novel urotensin II receptor antagonist, KR-36676, prevents ABCA1 repression via ERK/IL-1β pathway.

Kim MY, Ilyosbek S, Lee BH, Yi KY, Jung YS. Kim MY, et al. Among authors: yi ky. Eur J Pharmacol. 2017 May 15;803:174-178. doi: 10.1016/j.ejphar.2017.03.056. Epub 2017 Mar 28. Eur J Pharmacol. 2017. PMID: 28363746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters